CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+2.85%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(+2.8%)
Cap. Flow
+$1.98M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
35.89%
Holding
98
New
17
Increased
24
Reduced
4
Closed
13
Top Buys
| 1 |
Coterra Energy
CTRA
|
$2.09M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$1.93M |
| 3 |
BP
BP
|
$1.59M |
| 4 |
Intel
INTC
|
$1.4M |
| 5 |
Citigroup
C
|
$1.13M |
Top Sells
| 1 |
inTEST
INTT
|
$3.66M |
| 2 |
Merck
MRK
|
$1.85M |
| 3 |
Exelixis
EXEL
|
$1.81M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
$1.63M |
| 5 |
Energy Transfer Partners
ET
|
$1.54M |
Sector Composition
| 1 | Healthcare | 36.58% |
| 2 | Financials | 14.24% |
| 3 | Technology | 13.07% |
| 4 | Energy | 11.74% |
| 5 | Materials | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
National Healthcare
NHC
$1.74B
| $1.75M | 1.26% |
25,000
+5,000
| +25% | +$350K |
|
|
TAST
27
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.74M | 1.26% |
290,000
+31,435
| +12% | +$189K |
|
28
Viatris
VTRS
$12.3B
| $1.72M | 1.24% |
120,000
| – | – |
|
29
Cartesian Therapeutics
RNAC
$267M
| $1.67M | 1.21% |
400,000
| – | – |
|
30
First Financial Corporation Common Stock
THFF
$704M
| $1.63M | 1.18% |
40,000
+4,000
| +11% | +$163K |
|
31
Battalion Oil
BATL
$18.8M
| $1.59M | 1.15% |
118,289
-1,711
| -1% | -$22.9K |
|
|
32
BP
BP
$88.8B
| $1.59M | 1.15% |
+60,000
| New | +$1.59M |
|
|
33
Intel
INTC
$105B
| $1.4M | 1.01% |
+25,000
| New | +$1.4M |
|
34
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $1.38M | 1% |
100,000
+25,000
| +33% | +$346K |
|
35
ARKO Corp
ARKO
$548M
| $1.38M | 1% |
150,000
+20,000
| +15% | +$184K |
|
36
Bristow Group
VTOL
$1.07B
| $1.36M | 0.98% |
53,000
| – | – |
|
|
NWLI
37
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.35M | 0.97% |
6,000
| – | – |
|
38
Bristol-Myers Squibb
BMY
$96.7B
| $1.34M | 0.97% |
20,000
| – | – |
|
39
IAMGOLD
IAG
$5.47B
| $1.33M | 0.96% |
450,000
+100,000
| +29% | +$295K |
|
40
BioCardia
BCDA
$11.8M
| $1.31M | 0.94% |
329,000
+15,900
| +5% | +$63.1K |
|
41
PTC Therapeutics
PTCT
$4.41B
| $1.27M | 0.92% |
30,000
+5,000
| +20% | +$211K |
|
42
CVS Health
CVS
$93B
| $1.25M | 0.9% |
15,000
| – | – |
|
43
Elicio Therapeutics
ELTX
$169M
| $1.22M | 0.88% |
93,750
| – | – |
|
44
Plains GP Holdings
PAGP
$3.71B
| $1.19M | 0.86% |
100,000
+30,000
| +43% | +$358K |
|
|
PRTK
45
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.19M | 0.86% |
175,000
+25,000
| +17% | +$171K |
|
46
Cytosorbents Corp
CTSO
$61.5M
| $1.13M | 0.82% |
150,000
+30,000
| +25% | +$227K |
|
|
47
Citigroup
C
$175B
| $1.13M | 0.82% |
+16,000
| New | +$1.13M |
|
|
AVTA
48
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.13M | 0.81% |
65,000
-35,000
| -35% | -$606K |
|
|
SPPI
49
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.13M | 0.81% |
300,000
| – | – |
|
50
Saic
SAIC
$5.35B
| $1.1M | 0.79% |
+12,500
| New | +$1.1M |
|